ACAD

ACADIA PHARMACEUTICALS INC

Healthcare | Mid Cap

$0.15

EPS Forecast

$275.9

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
SAGESage Therapeutics IncPCRXPacira Biosciences IncPTCTPtc Therapeutics IncINVAInnoviva IncPBHPrestige Consumer Healthcare IncPAHCPhibro Animal Health CorpQUREUniqure NvUTHRUnited Therapeutics Corp